Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.22.1
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 10,014,132 17,549,173
Convertible notes    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 4,920,000
Warrants    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 5,636,801 5,996,112
Options    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 897,229 1,087,033
Restricted stock units    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 3,480,102 5,545,454
Restricted shares    
Debt Instrument [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 574